Skip to search formSkip to main content
You are currently offline. Some features of the site may not work correctly.

Diquafosol Tetrasodium

 
National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2018
2018
BackgroundTo investigate therapeutic effects of topical diquafosol tetrasodium 3% ophthalmic solution in patients with short tear… Expand
  • table 1
  • table 2
  • figure 1
  • table 3
Is this relevant?
2017
2017
This study aimed to compare the cellular toxicities of three clinically used dry eye treatments; 3% diquafosol tetrasodium and… Expand
  • figure 2
  • figure 1
  • figure 3
  • figure 4
  • table 1
Is this relevant?
2016
2016
Purpose: The aim of this study was to evaluate the clinical effect of 3% diquafosol in dry eye patients aged around 60 years… Expand
  • figure 1
  • table 1
  • figure 2
  • figure 4
Is this relevant?
2016
2016
PURPOSE To evaluate the efficacy of topical application of 3% diquafosol tetrasodium solution for the treatment of soft contact… Expand
Is this relevant?
2015
2015
Purpose: To evaluate the clinical efficacy of topical diquafosol tetrasodium 3% ophthalmic solution in patients with short tear… Expand
  • figure 1
  • table 1
  • table 2
Is this relevant?
2014
2014
PURPOSE To evaluate the possible advantages of combination therapy with diquafosol tetrasodium and sodium hyaluronate for dry eye… Expand
Is this relevant?
2014
2014
PURPOSE To evaluate the effect of diquafosol tetrasodium (DQS) for the treatment of persistent dry eye after laser in situ… Expand
Is this relevant?
2013
2013
PURPOSE To investigate the effect of diquafosol tetrasodium on tear and visual function in short break-up time (sBUT) dry eye (DE… Expand
Is this relevant?
2012
2012
PurposeTo assess the additive effect of diquafosol tetrasodium on sodium hyaluronate monotherapy in patients with dry eye… Expand
  • table 1
  • figure 1
  • figure 2
  • figure 3
  • figure 4
Is this relevant?
Highly Cited
2004
Highly Cited
2004
PURPOSE To investigate the safety and efficacy of diquafosol tetrasodium, a P2Y2 receptor agonist that stimulates fluid and mucin… Expand
Is this relevant?